CDMO Profile

Pfizer CentreOne

Pfizer Contract Manufacturing & Development (CDMO) Profile

Pfizer CentreOne, an award-winning global Contract Development and Manufacturing Organization (CDMO), leveraging Pfizer’s scientific and technical expertise.

With a focus on innovation and cutting-edge technology, we offer contract development and manufacturing services for oral solids, sterile injectables, small molecules, and biologics as well as regulatory services.
At Pfizer CentreOne, we understand the importance of quality and reliability. From the initial stages of development to full-scale commercialization, we prioritize the success of your product because for the patient, time is life.
For more information, visit www.pfizercentreone.com.

CDMO Services:
API and/or Ingredients; Finished Dosage Forms (Small Molecule Drugs); Biologics; Cell & Gene Therapy; Packaging Cartridges; Liquids; Lyophilized amps/vials; Pre-Filled Syringes (PFS); Solids; Sterile Ampoules; Sterile Vials Analytical Development; Drug Delivery System; Formulation Development; ICH Stability Testing; Process Development; Protein Synthesis Antibodies; Antibody-drug conjugate (ADC); Recombinants + other Proteins; mRNA Vaccines; Viral Vector Vaccines; Plasmid DNA

Year Founded: 1849

Head Office: New York, United States

Number of Facilities: More than 10

Facility locations: Europe; North America; Oceania

Website: Visit the Pfizer website

Linkedin: Connect on Linkedin

Sign up to the free weekly newsletter for all the latest news, resources and podcasts in contract manufacturing.  Register here

Experience the future of contract manufacturing

Join us at CDMO Live, 7-8 May 2025 in Rotterdam for an exclusive live event dedicated to contract manufacturing partnerships. Apply for your ticket.

INFOGRAPHIC

Download the latest infographic summarising key players in Small Molecule, Biologics and Cell & Gene Therapies.

Who do you rate?
Recommend a Supplier

Help us find the most innovative and trusted suppliers in Pharma and Biotech.